No physical activity x CETP 1b.-629 interaction effects on lipid profile

Medicine and Science in Sports and Exercise

Volumn 35, Issue 7, 2003, Pages 1124-1129

  Bernstein, Martine S ^a   Costanza, Michael C ^a,b   James, Richard W ^b   Morris, Michael A ^a   Cambien, François ^c   Raoux, Ségolène ^c   Morabia, Alfredo ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cholesterol; Cholesteryl ester tranfer protein; Energy expenditure; Exercise; High low density lipoprotein cholesterol; Triglycerides

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DETERMINATION; ENERGY EXPENDITURE; EXON; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHYSICAL ACTIVITY; POPULATION RESEARCH; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SITTING; SWITZERLAND;

EID: 0037678735     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.MSS.0000074444.27594.B0     Document Type: Article

References (28)

1. BERNSTEIN, M., D. SLOUTSKIS, S. KUMANYIKA, A. SPARTI, Y. SCHUTZAND, and A. MORABIA. Data-based approach for developing a physical activity frequency questionnaire. Am. J. Epidemiol. 147:147-154, 1998.
2. BERNSTEIN, M. S., M. C. COSTANZA, R. W. JAMES, et al. Physical activity may modulate effects of ApoE genotype on lipid profile. Arterioscler. Thromb. Vasc. Biol. 22:133-140, 2002.
3. BRUCE, C., and A. R. TALL. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis. Curr. Opin. Lipidol. 6:306-311, 1995.
4. CORBEX, M., O. POIRIER, F. FUMERON, et al. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet. Epidemiol. 19:64-80, 2000.
5. CORELLA, D., C. SAIZ, M. GUILLEN, et al. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population. Atherosclerosis 152:367-376, 2000.
6. COUILLARD, C., J. P. DESPRES, B. LAMARCHE, et al. Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler. Thromb. Vasc. Biol. 21:1226-1232, 2001.
7. CROUSE, S. F., B. C. O'BRIEN, P. W. GRANDJEAN, et al. Training intensity, blood lipids, and apolipoproteins in men with high cholesterol. J. Appl. Physiol. 82:270-277, 1997.
8. DACHET, C., O. POIRIER, F. CAMBIEN, J. CHAPMANAND, and M. ROUIS. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and HDL cholesterol levels: role of Spl/Sp3 in transcriptional regulation. Arterioscler. Thromb. Vasc. Biol. 20:507-515, 2000.
9. FREEMAN, D. J., B. A. GRIFFFN, A. P. HOLMES, et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors: associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler. Thromb. 14:336-344, 1994.
10. FRIEDEWALD, W. T., R. I. LEVYAND, and D. S. FREDRICKSON. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:499-502, 1972.
11. GIADA, F., G. B. VIGNA, E. VITALE, et al. Effect of age on the response of blood lipids, body composition, and aerobic power to physical conditioning and deconditioning. Metabolism 44:161-165, 1995.
12. GUPTA, A. K., E. A. Ross, J. N. MYERSAND, and M. L. KASHYAP. Increased reverse cholesterol transport in athletes. Metabolism 42:684-690, 1993.
13. HANNUKSELA, M. L., M. J. LIINAMAA, Y. A. KESANIEMIAND, and M. J. SAVOLAINEN. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis 110:35-44, 1994.
14. JAMES, R. W., C. VOLIOTIS, B. GRABAND, and D. POMETTA. Apoprotein e (apo e) phenotype and serum lipids in diabetics [Phenotypes de l'apoproteine E (apo E) et lipides seriques des diabetiques]. Schweiz Med. Wochenschr. 117:2021-2023, 1987.
15. KARK, J. D., R. SINNREICH, E. LEITERSDORF, Y. FRIEDLANDER, S. SHPITZENAND, and G. LUC. TaqIB CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol. Atherosclerosis 151:509-518, 2000.
16. KUIVENHOVEN, J. A., J. W. JUKEMA, A. H. ZWINDERMAN, et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis: the Regression Growth Evaluation Statin Study Group. N. Engl. J. Med. 338:86-93, 1998.
17. MARRUGAT, J., R. ELOSUA, M. I. COVAS, L. MOLINAAND, and J. RUBIES-PRAT. Amount and intensity of physical activity, physical fitness, and serum lipids in men: the marathon investigators. Am. J. Epidemiol. 143:562-569, 1996.
18. MORABIA, A., M. BERNSTEIN, S. KUMANYIKA, et al. Development and validation of a semi-quantitative food questionnaire based on a population survey [Développement et validation d'un questionnaire alimentaire semi-quantitatif à partir d'une enquête de population]. Soz. Praventivmed. 39:345-369, 1994.
19. MORIYAMA, Y., T. OKAMURA, A. INAZU, et al. A low prevalence of coronary heart diseases among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. Prev. Med. 27:659-667, 1998.
20. ORDOVAS, J. M., L. A. CUPPLES, D. CORELLA, et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart diseases risk: the Framingham study. Arterioscler. Thromb. Vasc. Biol. 20:1323-1329, 2000.
21. RUBINSTEIN, A., R. BURSTEIN, F. LUBIN, et al. Lipoprotein profile changes during intense training of Israeli military recruits. Med. Sci. Sports Exerc. 27:480-484, 1995.
22. SEIP, R. L., T. J. ANGELOPOULOSAND, and C. F. SEMENKOVICH. Exercise induces human lipoprotein lipase gene expression in skeletal muscle but not adipose tissue. Am. J. Physiol. 268:E229-E236, 1995.
23. SEIP, R. L., P. MOULIN, T. COCKE, et al. Exercise training decreases plasma cholesteryl ester transfer protein. Arterioscler. Thromb. 13:1359-1367, 1993.
24. TALL, A. R. An overview of reverse cholesterol transport. Eur. Heart J. 19(Suppl. A):A31-A35, 1998.
25. WORLD HEALTH ORGANIZATION (WHO). Energy and Protein Requirements. WHO Technical Report Series 724, Geneva, Switzerland, 1985.
26. WILUND, K. R., R. E. FERRELL, D. A. PHARES, A. P. GOLDBERGAND, and J. M. HAGBERG. Changes in high-density lipoprotein-cholesterol subfractions with exercise training may be dependent on cholesteryl ester transfer protein (CETP) genotype. Metabolism 51:774-778, 2002.
27. WOOLF-MAY, K., E. M. KEARNEY, D. W. JONES, R. C. DAVISON, D. COLEMANAND, S. R. BIRD. The effect of two different 18-week walking programmes on aerobic fitness, selected blood lipids and factor XIIa. J. Sports Sci. 16:701-710, 1998.
28. YAMASHITA, S., N. SAKAI, K. HIRANO, et al. Roles of plasma lipid transfer proteins in reverse cholesterol transport. Front. Biosci. 6:D366-D387, 2001.